Citation: | Xuefeng Zhang, Hao Xu, Tong Zhou, Xiaodong Feng, Qianming Chen. Prognostic significance of SOX2 for chemotherapeutic patients with oral squamous cell carcinoma[J]. Journal of Pharmaceutical Analysis, 2024, 14(4): 100908. doi: 10.1016/j.jpha.2023.11.015 |
[1] |
A.C. Chi, T.A. Day, B.W. Neville, Oral cavity and oropharyngeal squamous cell carcinoma-an update, CA Cancer J. Clin. 65 (2015) 401-421.
|
[2] |
T.Y. Seiwert, J.K. Salama, E.E. Vokes, The chemoradiation paradigm in head and neck cancer, Nat. Clin. Pract. Oncol. 4 (2007) 156-171.
|
[3] |
K. Takahashi, K. Tanabe, M. Ohnuki, et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell 131 (2007) 861-872.
|
[4] |
X. Qiu, S. Jiang, Y. Xiao, et al., SOX2-dependent expression of dihydroorotate dehydrogenase regulates oral squamous cell carcinoma cell proliferation, Int. J. Oral. Sci. 13 (2021), 3.
|
[5] |
M.-Y. Chou, F.-W. Hu, C.-H. Yu, et al., Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells, Oral Oncol. 51 (2015) 31-39.
|